Partha Ray Selected Research

pirlimycin

3/2020	Fate of pirlimycin and antibiotic resistance genes in dairy manure slurries in response to temperature and pH adjustment.
11/2014	Method development and validation: solid Phase extraction-ultra performance liquid chromatography-tandem mass spectrometry quantification of pirlimycin in bovine feces and urine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Partha Ray Research Topics

Disease

10	Neoplasms (Cancer) 04/2022 - 07/2006
6	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 05/2012
2	Adenocarcinoma 04/2022 - 01/2020
2	COVID-19 05/2021 - 01/2021
2	Shock 03/2020 - 03/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Necrosis 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2016
1	Infectious Arthritis (Septic Arthritis) 01/2016
1	Ataxia (Dyssynergia) 01/2016
1	Ataxia with vitamin E deficiency 01/2016
1	Mastitis 11/2014
1	Melanoma (Melanoma, Malignant) 08/2011
1	Breast Neoplasms (Breast Cancer) 07/2006
1	Neoplasm Metastasis (Metastasis) 07/2006
1	Carcinoma (Carcinomatosis) 07/2006

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2016
3	Nucleotide AptamersIBA 01/2020 - 10/2012
2	pirlimycinIBA 03/2020 - 11/2014
2	Gemcitabine FDA Link 01/2020 - 10/2012
2	cyclophilin BIBA 12/2013 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 12/2013 - 05/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	AntigensIBA 05/2021
1	Antiviral Agents (Antivirals)IBA 05/2021
1	VaccinesIBA 05/2021
1	Conditioned Culture MediaIBA 01/2021
1	SolutionsIBA 12/2020
1	MacrolidesIBA 03/2020
1	Isoantigens (Alloantigen)IBA 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	RNA Helicases (RNA Helicase)IBA 04/2016
1	C-Reactive ProteinIBA 01/2016
1	alpha-tocopherol transfer proteinIBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2014
1	PolymersIBA 10/2012
1	NucleosidesIBA 10/2012
1	Pharmaceutical PreparationsIBA 10/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2012
1	ErbB Receptors (EGF Receptor)IBA 10/2012
1	RNA (Ribonucleic Acid)IBA 05/2012
1	LigandsIBA 05/2012
1	Phosphotransferases (Kinase)IBA 07/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2006
1	Transforming Growth Factor-beta Type I ReceptorIBA 07/2006
1	SD-208IBA 07/2006

Therapy/Procedure

4	Therapeutics 05/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 04/2022 - 10/2012
2	Precision Medicine 01/2021 - 01/2020
2	Ablation Techniques 10/2019 - 01/2018
1	Neurological Rehabilitation 01/2021
1	Metastasectomy 08/2011